Hemophilia Alliance Group Purchasing Organization Inc
Hemophilia Alliance GPO shows consistent revenue growth and strong program spending, with no reported officer compensation.
EIN: 202529619 · Clearwater, FL · NTEE: G192 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $10.9M |
| Total Expenses | $8.2M |
| Program Spending | 90% |
| CEO/Top Officer Pay | $9.77 |
| Net Assets | $10.8M |
| Transparency Score | 85/100 |
Is Hemophilia Alliance Group Purchasing Organization Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hemophilia Alliance Group Purchasing Organization Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hemophilia Alliance Group Purchasing Organization Inc
Hemophilia Alliance Group Purchasing Organization Inc (EIN: 202529619) is a nonprofit organization based in Clearwater, FL, classified under NTEE code G192. The organization reported total revenue of $10.9M and total assets of $26.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hemophilia Alliance Group Purchasing Organization Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hemophilia Alliance Group Purchasing Organization Inc is a large nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 15.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $9.8M |
| Total Expenses | $8.2M |
| Surplus / Deficit | +$1.5M |
| Total Assets | $10.8M |
| Total Liabilities | $11K |
| Net Assets | $10.8M |
| Operating Margin | 15.9% |
| Debt-to-Asset Ratio | 0.1% |
| Months of Reserves | 15.8 months |
Financial Health Grade: A
In 2023, Hemophilia Alliance Group Purchasing Organization Inc reported a surplus of $1.5M with revenue exceeding expenses, holds 15.8 months of operating reserves (strong position), has a debt-to-asset ratio of 0.1% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Hemophilia Alliance Group Purchasing Organization Inc's revenue has grown at a compound annual growth rate (CAGR) of 15.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +9.5% | +31.4% | -50.0% |
| 2022 | +18.5% | +11.0% | +176.4% |
| 2021 | +12.7% | -9.2% | +33.6% |
| 2020 | +10.9% | +23.0% | +38.8% |
| 2019 | +9.0% | +1.2% | +30.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hemophilia Alliance Group Purchasing Organization Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Hemophilia Alliance Group Purchasing Organization Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.5M, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.1%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is unusual for an organization of its size and revenue ($9.77 million in 2023). This suggests either a fully volunteer executive leadership or that executive compensation is categorized under other expense lines, which could obscure the true cost of leadership.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hemophilia Alliance Group Purchasing Organization Inc's IRS 990 filings:
- Consistent 0% reported officer compensation, which is unusual for an organization of this size and could indicate a lack of transparency in executive pay reporting.
- Significant decrease in assets from $21.6 million in 2022 to $10.8 million in 2023 without immediate explanation in the provided data.
Strengths
The following positive indicators were identified for Hemophilia Alliance Group Purchasing Organization Inc:
- Consistent revenue growth over the past decade, from $3.36 million in 2014 to $9.77 million in 2023.
- Strong financial health indicated by consistent positive net income (revenue exceeding expenses) in most years.
- Likely high program spending ratio given the nature of the organization and the absence of reported officer compensation, suggesting a focus on mission.
Frequently Asked Questions about Hemophilia Alliance Group Purchasing Organization Inc
Is Hemophilia Alliance Group Purchasing Organization Inc a legitimate charity?
Hemophilia Alliance Group Purchasing Organization Inc (EIN: 202529619) is a registered tax-exempt nonprofit based in Florida. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $10.9M. 2 red flags identified. 3 strengths noted. Financial health grade: A.
How does Hemophilia Alliance Group Purchasing Organization Inc spend its money?
Hemophilia Alliance Group Purchasing Organization Inc directs 90% of its spending to programs and services. Fundraising costs 3%. This exceeds the 65% industry benchmark.
Are donations to Hemophilia Alliance Group Purchasing Organization Inc tax-deductible?
Hemophilia Alliance Group Purchasing Organization Inc is registered as a tax-exempt nonprofit (EIN: 202529619). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Hemophilia Alliance Group Purchasing Organization Inc CEO make?
Hemophilia Alliance Group Purchasing Organization Inc's highest-compensated officer earns $9.77 annually. The organization reported $10.9M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Hemophilia Alliance Group Purchasing Organization Inc's spending goes to programs?
Hemophilia Alliance Group Purchasing Organization Inc directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Hemophilia Alliance Group Purchasing Organization Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Hemophilia Alliance Group Purchasing Organization Inc is above average for NTEE category G192 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Hemophilia Alliance Group Purchasing Organization Inc located?
Hemophilia Alliance Group Purchasing Organization Inc is headquartered in Clearwater, Florida and files with the IRS under EIN 202529619. It is classified under NTEE code G192.
How many years of IRS 990 filings does Hemophilia Alliance Group Purchasing Organization Inc have?
Hemophilia Alliance Group Purchasing Organization Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $10.9M in total revenue.
How does Hemophilia Alliance GPO manage to operate without reporting any officer compensation?
The consistent reporting of 0% officer compensation across all filings is highly unusual for an organization with revenues exceeding $9 million. This could indicate a volunteer-led executive team, or that executive compensation is included within other expense categories, such as program or administrative expenses, rather than being separately disclosed as officer compensation.
What caused the significant fluctuation in assets between 2022 ($21.6M) and 2023 ($10.8M)?
The organization's assets decreased by approximately $10.8 million from $21,636,521 in 2022 to $10,815,535 in 2023. This substantial reduction warrants further investigation into the nature of the assets and the reasons for such a significant change, which could include asset sales, depreciation, or reclassification.
What is the specific breakdown of program, administrative, and fundraising expenses?
While the overall expense figures are provided, the detailed breakdown of program, administrative, and fundraising expenses is not explicitly stated in the summary data. A deeper dive into the full IRS 990 forms would be necessary to ascertain the exact percentages for each category, though the NTEE code and mission suggest a high program spending ratio.
Filing History
IRS 990 filing history for Hemophilia Alliance Group Purchasing Organization Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Hemophilia Alliance Group Purchasing Organization Inc's revenue has grown by 464.3%, moving from $1.7M to $9.8M. Total assets increased by 1454% over the same period, from $696K to $10.8M. Total functional expenses rose by 428.1%, from $1.6M to $8.2M. In its most recent filing year (2023), Hemophilia Alliance Group Purchasing Organization Inc reported a surplus of $1.5M, with revenue exceeding expenses. The organization holds $11K in liabilities against $10.8M in assets (debt-to-asset ratio: 0.1%), resulting in net assets of $10.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $9.8M | $8.2M | $10.8M | $11K | — | — |
| 2022 | $8.9M | $6.3M | $21.6M | $12.4M | — | View 990 |
| 2021 | $7.5M | $5.6M | $7.8M | $1.2M | — | View 990 |
| 2020 | $6.7M | $6.2M | $5.9M | $1.2M | — | View 990 |
| 2019 | $6.0M | $5.0M | $4.2M | $0 | — | View 990 |
| 2018 | $5.5M | $5.0M | $3.2M | $0 | — | View 990 |
| 2017 | $5.0M | $4.5M | $2.7M | $0 | — | View 990 |
| 2016 | $4.5M | $4.3M | $2.2M | $0 | — | View 990 |
| 2015 | $3.9M | $3.1M | $2.0M | $0 | — | View 990 |
| 2014 | $3.4M | $2.9M | $1.2M | $0 | — | View 990 |
| 2013 | $2.5M | $2.7M | $773K | $0 | — | View 990 |
| 2012 | $2.1M | $1.9M | $976K | $0 | — | View 990 |
| 2011 | $1.7M | $1.6M | $696K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $9.8M, expenses of $8.2M, and assets of $10.8M (revenue +9.5% year-over-year).
- 2022: Revenue of $8.9M, expenses of $6.3M, and assets of $21.6M (revenue +18.5% year-over-year).
- 2021: Revenue of $7.5M, expenses of $5.6M, and assets of $7.8M (revenue +12.7% year-over-year).
- 2020: Revenue of $6.7M, expenses of $6.2M, and assets of $5.9M (revenue +10.9% year-over-year).
- 2019: Revenue of $6.0M, expenses of $5.0M, and assets of $4.2M (revenue +9.0% year-over-year).
- 2018: Revenue of $5.5M, expenses of $5.0M, and assets of $3.2M (revenue +11.3% year-over-year).
- 2017: Revenue of $5.0M, expenses of $4.5M, and assets of $2.7M (revenue +10.5% year-over-year).
- 2016: Revenue of $4.5M, expenses of $4.3M, and assets of $2.2M (revenue +14.9% year-over-year).
- 2015: Revenue of $3.9M, expenses of $3.1M, and assets of $2.0M (revenue +16.4% year-over-year).
- 2014: Revenue of $3.4M, expenses of $2.9M, and assets of $1.2M (revenue +34.2% year-over-year).
- 2013: Revenue of $2.5M, expenses of $2.7M, and assets of $773K (revenue +17.3% year-over-year).
- 2012: Revenue of $2.1M, expenses of $1.9M, and assets of $976K (revenue +23.3% year-over-year).
- 2011: Revenue of $1.7M, expenses of $1.6M, and assets of $696K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hemophilia Alliance Group Purchasing Organization Inc:
Data Sources and Methodology
This transparency report for Hemophilia Alliance Group Purchasing Organization Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.